Maybe this is the rumor???
FDA news Drug Daily Bulletin >
Teva: Clinical Trials Necessary to Approve a Copaxone Generic
FDAnews Drug Daily Bulletin
Aug. 6, 2010 | Vol. 7 No. 153
Teva: Clinical Trials Necessary to Approve a Copaxone Generic
Any generic of Teva’s blockbuster multiple sclerosis treatment Copaxone would need clinical trials to gain approval, the company says in response to speculation that the FDA might approve a generic Copaxone using the same criteria it applied to generic Lovenox. “In the case of Copaxone and other complex molecules, there are no acceptable … tests either in humans or animals that can be relied upon except for complete clinical tests, which reflect the clinical outcome in multiple sclerosis,” Teva CEO Shlomo Yanai said.
